Development of hyperdiploidy starts at an early age and takes a decade to complete

M Mehmet K. Samur (Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, United States) A Anil Aktas Samur (Dana Farber Cancer Institution, Boston, Massachusetts, United States) P Parth Shah J Joseph S. Park (3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA) M Mariateresa Fulciniti (Dana Farber Cancer Institute, Boston, Massachusetts, United States) M Masood Shammas (5Dana Farbar (Harvard) Cancer Institute, Molecular Oncology, Boston, United States) J Jill Corre (Unité Génomique du Myélome, Hôpital Universitaire de Toulouse Oncopole, Université de Toulouse, Toulouse, France) K Kenneth C. Anderson G Giovanni Parmigiani H Hervé Avet-Loiseau (Unité Génomique du Myélome, Hôpital Universitaire de Toulouse Oncopole, Université de Toulouse, Toulouse, France) N Nikhil C. Munshi

Abstract

Abstract Nearly half of patients with multiple myeloma (MM) have hyperdiploidy (HMM) at diagnosis. Although HMM occurs early, the mutational processes before and after hyperdiploidy are still unclear. Here, we used 72 whole-genome sequencing samples from patients with HMM and identified pre- and post-HMM mutations to define the chronology of the development of hyperdiploidy. An MM cell accumulated a median of 0.56 mutations per megabase before HMM, and for every clonal pre-HMM mutation, 1.21 mutations per megabase accumulated after HMM. This analysis using mutations before and after hyperdiploidy shows that hyperdiploidy happens after somatic hypermutation. Prehyperdiploidy mutations are activation-induced cytidine deaminase and age/clock-like signature driven, whereas posthyperdiploidy mutations are from DNA damage and APOBEC. Interestingly, the first hyperdiploidy event occurred within the first 3 decades of life and took a decade to complete. Copy number changes affecting chromosomes 15 and 19 occurred first. Finally, mutations before initiating event affected chromosomes at different rates, whereas post–initiating event mutational processes affect each chromosome equally.

Article Details

Journal Blood
Volume / Issue Vol. 145, Issue 5
Published January 30, 2025
Pages 520-525
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (11)

M

Mehmet K. Samur

Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, United States

A

Anil Aktas Samur

Dana Farber Cancer Institution, Boston, Massachusetts, United States

P

Parth Shah

J

Joseph S. Park

3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

M

Mariateresa Fulciniti

Dana Farber Cancer Institute, Boston, Massachusetts, United States

M

Masood Shammas

5Dana Farbar (Harvard) Cancer Institute, Molecular Oncology, Boston, United States

J

Jill Corre

Unité Génomique du Myélome, Hôpital Universitaire de Toulouse Oncopole, Université de Toulouse, Toulouse, France

K

Kenneth C. Anderson

G

Giovanni Parmigiani

H

Hervé Avet-Loiseau

Unité Génomique du Myélome, Hôpital Universitaire de Toulouse Oncopole, Université de Toulouse, Toulouse, France

N

Nikhil C. Munshi